New Zealand markets close in 30 minutes
  • NZX 50

    11,735.94
    +33.13 (+0.28%)
     
  • NZD/USD

    0.6284
    -0.0003 (-0.05%)
     
  • NZD/EUR

    0.6162
    -0.0001 (-0.02%)
     
  • ALL ORDS

    7,278.80
    +19.30 (+0.27%)
     
  • ASX 200

    7,030.40
    +9.80 (+0.14%)
     
  • OIL

    90.58
    -0.18 (-0.20%)
     
  • GOLD

    1,802.00
    -3.20 (-0.18%)
     
  • NASDAQ

    13,159.16
    -48.53 (-0.37%)
     
  • FTSE

    7,482.37
    +42.63 (+0.57%)
     
  • Dow Jones

    32,832.54
    +29.07 (+0.09%)
     
  • DAX

    13,687.69
    +113.76 (+0.84%)
     
  • Hang Seng

    20,228.71
    +182.94 (+0.91%)
     
  • NIKKEI 225

    27,985.02
    -264.22 (-0.94%)
     
  • NZD/JPY

    84.7120
    -0.1220 (-0.14%)
     

This May Be Pfizer's Key to Long-Term Vaccine Dominance

·3-min read

Pfizer (NYSE: PFE) is already the leader in the coronavirus vaccine space. Rival Moderna (NASDAQ: MRNA) has a significant position in the market. Latecomer Novavax (NASDAQ: NVAX) could also take market share in the months to come.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting